Overview

Fixed-dose Combination of an Angiotensin Receptor Blocker and Thiazide Diuretic for Essential Hypertension

Status:
NOT_YET_RECRUITING
Trial end date:
2029-10-30
Target enrollment:
Participant gender:
Summary
This is a phase III, non-inferiority, randomized, double-blind, double-dummy, active-controlled, multicenter study to compare the efficacy and safety of N0877 versus double combination with already established efficacy on systolic blood pressure (SBP) in the sitting position in the medical office in patients with SAH after 8 weeks of treatment.
Phase:
PHASE3
Details
Lead Sponsor:
Eurofarma Laboratorios S.A.